Plasma cell dyscrasia-related glomerulopathies and Fanconi's syndrome: A molecular approach

Journal of Nephrology

Volumn 13, Issue 3 SUPPL., 2000, Pages

  Ronco, Pierre ^a,b   Aucouturier, Pierre ^a   Mougenot, Béatrice ^a  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

Chronic lymphocytic leukemia; Fibrillary glomerulonephritis; Ig heavy chain deposition disease; Immunotactoid glomerulopathy; Light chain amyloidosis; Light chain Fanconi's syndrome; Monoclonal immunoglobulin deposition disease; Myeloma; POEMS syndrome

Indexed keywords

IMMUNOGLOBULIN;

AMYLOIDOSIS; ELECTRON MICROSCOPY; FANCONI RENOTUBULAR SYNDROME; GENETICS; GLOMERULUS; HUMAN; KIDNEY DISEASE; METABOLISM; PARAPROTEINEMIA; PATHOLOGY; REVIEW;

AMYLOIDOSIS; FANCONI SYNDROME; HUMANS; IMMUNOGLOBULINS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MICROSCOPY, ELECTRON; PARAPROTEINEMIAS;

EID: 0034320619     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Preud'homme JL, Morel-Maroger L, Brouet JC, Mihaesco E, Mery JP, Seligmann M. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol 1980; 42: 545-53.
2. Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991; 324: 1845-51.
3. Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones east nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114: 986-7.
4. Glenner GG. Amyloid deposits and amyloidosis: the β-fibrilloses. N Engl J Med 1980; 302: 1283-92.
5. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59.
6. Kyle RA, Greipp PR. Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58: 665-83.
7. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997; 336: 1202-7.
8. Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M. Dose-intensive melphalan until blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood 1998; 91: 3662-70.
9. Randall RE, Williamson WC, Mullinax F, Tung MY, Still WJS. Manifestations of systemic light chain deposition Am J Med 1976; 60: 293-9.
10. Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogné M, Chauffert B, Martin F, Preud'homme JL. Brief report: heavy-chain deposition disease. N Engl J Med 1993; 329: 1389-93.
11. Moulin B, Deret S, Mariette X, Kourilsky O, Imai H, Dupouet L, Marcellin L, Kolb I, Aucouturier P, Brouet JC, Ronco PM, Mougenot B. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J Am Soc Nephrol 1999; 10: 519-28.
12. Ganeval D. Mignon F, Preud'homme JL, Noël LH, Morel-Maroger L, Droz D, Brouet JC, Méry JP, Grünfeld JP. Visceral deposition of monoclonal light chains and immunoglobulins: a study of renal and immunopathologic abnormalities. Adv Nephrol 1982; 11:25-63.
13. Confalonieri R, Barbiano di Belgiojoso G, Banfi G, Ferrario F, Bertani T, Pozzi C, Casanova S, Lupo A, De Ferrari G, Minetti L. Light chain nephropathy: histological and clinical aspects in 15 cases. Nephrol Dial Transplant 1988; 2: 150-6.
14. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990; 112:455-64.
15. Heilman RL, Velosa JA, Holley KE, Offord KP, Kyle RA. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 1992; 20: 34-41.
16. KIV subgroup in light chain deposition disease. Immunol Lett 1994; 42: 63-6.
17. Preud'homme JL, Aucouturier P, Touchard G, Striker L, Khamlichi AA, Rocca A, Denoroy L, Cogné M. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int 1994; 46: 965-72.